Insomnia symptoms double the risk of cardiovascular disease (CVD), yet shared genetic pathways remain unclear. Genome-wide association studies (GWAS) identified a genetic locus (near ATP5G1, UBE2Z, SNF8, IGF2BP1, and GIP) linked to insomnia and CVD. We used Drosophila models to perform tissue-specific RNAi knockdowns of four conserved orthologues (ATPSynC, Lsn, Bruce, and Imp) in neurons and the heart. Neuronal-specific knockdown of ATPSynC, Imp, and Lsn impaired sleep quantity and quality. In contrast, cardiac knockdown of ATPSynC and Lsn reduced cardiac function and lifespan, with Lsn knockdown also causing cardiac dilation and myofibrillar disorganization. Cross-tissue effects were evident: neuronal Imp knockdown compromised cardiac function, while cardiac ATPSynC and Lsn knockdown increased sleep fragmentation and inflammation (marked by Upd3 elevation in the heart or head). Overexpression of Upd3 in neurons impaired cardiac function, while its overexpression in the heart disrupted sleep. Our findings reveal conserved genes mediating tissue-specific and cross-tissue interactions between sleep and cardiac function, providing novel insights into genetic mechanisms linking insomnia and CVD through inflammation.
Identifying novel links between cardiovascular disease and insomnia by Drosophila modeling of genes from a pleiotropic GWAS locus
- Award Group:
- Funder(s): NHLBI Division of Intramural Research
- Award Id(s): HL146751
- Funder(s):
- Award Group:
- Funder(s): American Heart Association
- Award Id(s): 23PRE1020631
- Funder(s):
Farah Abou Daya, Torrey Mandigo, Lily Ober, Dev Patel, Matthew Maher, Suraj Math, Cynthia Tchio, James A. Walker, Richa Saxena, Girish C. Melkani; Identifying novel links between cardiovascular disease and insomnia by Drosophila modeling of genes from a pleiotropic GWAS locus. Dis Model Mech 2025; dmm.052139. doi: https://doi.org/10.1242/dmm.052139
Download citation file:
Advertisement
Cited by
Interviews with Biologists @ 100 conference speakers

Explore our interviews with keynote speakers from the Biologists @ 100 conference, hosted to celebrate our publisher’s 100th anniversary, where we discuss climate change and biodiversity with Hans-Otto Pörtner and Jane Francis, health and disease with Charles Swanton and emerging technologies with Manu Prakash and Jennifer Lippincott-Schwartz.
A new perspective on disease research
DMM publishes perspectives – peer-reviewed articles that provide expert analysis of a topic important to the disease research community. Read our collection from authors presenting new or potentially controversial ideas or hypotheses, to help address future challenges and forge new directions.
Read & Publish Open Access publishing: what authors say

We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Fast & Fair peer review

Our sister journal Biology Open has recently launched the next phase of their Fast & Fair peer review initiative: offering high-quality peer review within 7 working days. To learn more about BiO’s progress and future plans, read the Editorial by Daniel Gorelick, or visit the Fast & Fair peer review page.
History of our journals

As our publisher, The Company of Biologists, turns 100 years old, read about DMM’s history and explore the journey of each of our sister journals: Development, Journal of Cell Science, Journal of Experimental Biology and Biology Open.
Other journals from
The Company of Biologists